Sign up online today & collaborate
or click here to find out more
London, UK – Mereo, a UK-based specialty biopharmaceutical company, announces that its Ordinary Shares were admitted to trading on the AIM market of the London Stock Exchange at 8.00am GMT today. This follows a successful capital raise with total gross proceeds of £14.8 million. On admission the Company will have a market capitalisation of approximately £142 million.
Trading of the Ordinary Shares will take place under the ticker symbol “MPH” with ISIN GB00BZ4G2K23.
RBC Capital Markets is acting as Global Coordinator, Private Placement Agent and Broker to the Company and Cantor Fitzgerald Europe is acting as Nominated Adviser, Private Placement Agent and Broker. Evercore is acting as Financial Adviser to the Company.
|Company||Mereo Biopharma Group Limited|